Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
Acquired immunodeficiency syndrome and tuberculosis (TB) are two of the world's most devastating diseases. The first vaccine the majority of infants born in Africa receive is Mycobacterium bovis bacillus Calmette-Guérin (BCG) as a prevention against TB. BCG protects against disseminated disease...
Main Authors: | Richard Hopkins, Anne Bridgeman, Joan Joseph, Sarah C Gilbert, Helen McShane, Tomáš Hanke |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3094449?pdf=render |
Similar Items
-
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
by: Esther Broset, et al.
Published: (2019-06-01) -
Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice.
by: Kristin L Griffiths, et al.
Published: (2013-01-01) -
Immunisation strategies for enhancing T cell responses against M. tuberculosis
by: Mcshane, Helen Irene
Published: (2002) -
Local Pulmonary Immunological Biomarkers in Tuberculosis
by: Hazel Morrison, et al.
Published: (2021-03-01) -
Development of a novel adjuvant platform for neonatal vaccines against pertussis
Published: (2014)